|
1
|
Chen F, Chen C, Qu Y, Xiang H, Ai Q, Yang
F, Tan X, Zhou Y, Jiang G and Zhang Z: Selenium-binding protein 1
in head and neck cancer is low-expression and associates with the
prognosis of nasopharyngeal carcinoma. Medicine (Baltimore).
95:e45922016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang HZ, Cao CN, Luo JW, Yi JL, Huang XD,
Zhang SP, Wang K, Qu Y, Xiao JP, Li SY, et al: High-risk factors of
parotid lymph node metastasis in nasopharyngeal carcinoma: A
case-control study. Radiat Oncol. 11:1132016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang M, Wei S, Su L, Lv W and Hong J:
Prognostic significance of pretreated serum lactate dehydrogenase
level in nasopharyngeal carcinoma among Chinese population: A
meta-analysis. Medicine (Baltimore). 95:e44942016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung WW, Chu YC, Chen PR, Liao MH and Lee
JW: Positive regulation of HIF-1A expression by EBV oncoprotein
LMP1 in nasopharyngeal carcinoma cells. Cancer Lett. 382:21–31.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin PJ, Twu CW, Liu YC, Lin TY, Wang WY
and Lin JC: Comparison the clinical outcomes with altered versus
conventional fractionated radiotherapy plus concurrent chemotherapy
for advanced nasopharyngeal carcinoma. Head Neck. Feb 1–2018.(Epub
ahead of print). View Article : Google Scholar
|
|
6
|
Zhang L, Huang Y, Hong S, Yang Y, Yu G,
Jia J, Peng P, Wu X, Lin Q, Xi X, et al: Gemcitabine plus cisplatin
versus fluorouracil plus cisplatin in recurrent or metastatic
nasopharyngeal carcinoma: A multicentre, randomised, open-label,
phase 3 trial. Lancet. 388:1883–1892. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi P, Zhong J, Hong J, Huang R, Wang K
and Chen Y: Automated Ki-67 quantification of immunohistochemical
staining image of human nasopharyngeal carcinoma xenografts. Sci
Rep. 6:321272016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu VW, Leung WS, Wong KL, Chan YK, Law WL,
Leung WK and Yu YL: The impact of positron emission tomography on
primary tumour delineation and dosimetric outcome in intensity
modulated radiotherapy of early T-stage nasopharyngeal carcinoma.
Radiat Oncol. 11:1092016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zou ZW, Ma C, Medoro L, Chen L, Wang B,
Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, et al: LncRNA ANRIL is
up-regulated in nasopharyngeal carcinoma and promotes the cancer
progression via increasing proliferation, reprograming cell glucose
metabolism and inducing side-population stem-like cancer cells.
Oncotarget. 7:61741–61754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pearce SC, Al-Jawadi A, Kishida K, Yu S,
Hu M, Fritzky LF, Edelblum KL, Gao N and Ferraris RP: Marked
differences in tight junction composition and macromolecular
permeability among different intestinal cell types. BMC Biol.
16:192018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gonzalez-Mariscal L, Posadas-Torrentera Y,
Miranda J, Uc P, Ortega-Olvera JM and Hernandez S: Strategies that
target tight junctions for enhanced drug delivery. Curr Pharm Des.
22:1305–1311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salvador E, Burek M and Forster CY: Tight
junctions and the tumor microenvironment. Curr Pathobiol Rep.
4:135–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chaouche-Mazouni S, Scherpereel A, Zaamoum
R, Mihalache A, Amir ZC, Lebaïli N, Delaire B and Gosset P: Claudin
3, 4 and 15 expression in solid tumors of lung adenocarcinoma
versus malignant pleural mesothelioma. Ann Diagn Pathol.
19:193–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kudinov AE, Deneka A, Nikonova AS, Beck
TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, et
al: Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins
to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl
Acad Sci USA. 113:pp. 6955–6960. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwon MJ, Kim SH, Jeong HM, Jung HS, Kim
SS, Lee JE, Gye MC, Erkin OC, Koh SS, Choi YL, et al: Claudin-4
overexpression is associated with epigenetic derepression in
gastric carcinoma. Lab Invest. 91:1652–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okugawa T, Oshima T, Chen X, Hori K,
Tomita T, Fukui H, Watari J, Matsumoto T and Miwa H:
Down-regulation of claudin-3 is associated with proliferative
potential in early gastric cancers. Dig Dis Sci. 57:1562–1567.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Troy TC, Arabzadeh A, Yerlikaya S and
Turksen K: Claudin immunolocalization in neonatal mouse epithelial
tissues. Cell Tissue Res. 330:381–388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katoh M and Katoh M: CLDN23 gene,
frequently down-regulated in intestinal-type gastric cancer, is a
novel member of CLAUDIN gene family. Int J Mol Med. 11:683–689.
2003.PubMed/NCBI
|
|
19
|
Chen JJ, Zhong M, Dou TH, Wu ZY and Tang
WJ: rs17501976 polymorphism of CLDN1 gene is associated with
decreased risk of colorectal cancer in a Chinese population. Int J
Clin Exp Med. 8:1247–1252. 2015.PubMed/NCBI
|
|
20
|
Benczik M, Galamb A, Koiss R, Kovács A,
Járay B, Székely T, Szekerczés T, Schaff Z, Sobel G and Jeney C:
Claudin-1 as a biomarker of cervical cytology and histology. Pathol
Oncol Res. 22:179–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsueh C, Chang YS, Tseng NM, Liao CT,
Hsueh S, Chang JH, Wu IC and Chang KP: Expression pattern and
prognostic significance of claudins 1, 4 and 7 in nasopharyngeal
carcinoma. Hum Pathol. 41:944–950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cantelli G, Crosas-Molist E, Georgouli M
and Sanz-Moreno V: TGFB-induced transcription in cancer. Semin
Cancer Biol. 42:42–62. 2017. View Article : Google Scholar
|
|
23
|
Cardenas H, Zhao J, Vieth E, Nephew KP and
Matei D: EZH2 inhibition promotes epithelial-to-mesenchymal
transition in ovarian cancer cells. Oncotarget. 7:84453–84467.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin L, Yi J, Gao Y, Han S, He Z, Chen L
and Song H: MiR-630 inhibits invasion and metastasis in esophageal
squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai).
48:810–819. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chung YH, Li SC, Kao YH, Luo HL, Cheng YT,
Lin PR, Tai MH and Chiang PH: MiR-30a-5p inhibits
epithelial-to-mesenchymal transition and upregulates expression of
tight junction protein claudin-5 in human upper tract urothelial
carcinoma cells. Int J Mol Sci. 18:E18262017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
27
|
Cepollaro S, Della Bella E, de Biase D,
Visani M and Fini M: Evaluation of RNA from human trabecular bone
and identification of stable reference genes. J Cell Physiol.
233:4401–4407. 2017. View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Vicente JC, Fernandez-Valle A,
Vivanco-Allende B, Santamarta TR, Lequerica-Fernández P,
Hernández-Vallejo G and Allonca-Campa E: The prognostic role of
claudins −1 and −4 in oral squamous cell carcinoma. Anticancer Res.
35:2949–2959. 2015.PubMed/NCBI
|
|
30
|
Nakagawa S, Miyoshi N, Ishii H, Mimori K,
Tanaka F, Sekimoto M, Doki Y and Mori M: Expression of CLDN1 in
colorectal cancer: A novel marker for prognosis. Int J Oncol.
39:791–796. 2011.PubMed/NCBI
|
|
31
|
Fortier AM, Asselin E and Cadrin M:
Keratin 8 and 18 loss in epithelial cancer cells increases
collective cell migration and cisplatin sensitivity through
claudin1 up-regulation. J Biol Chem. 288:11555–11571. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jian Y, Chen C, Li B and Tian X:
Delocalized Claudin-1 promotes metastasis of human osteosarcoma
cells. Biochem Biophys Res Commun. 466:356–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang J, Zhang L, He C, Qu Y, Li J, Zhang
J, Du T, Chen X, Yu Y, Liu B and Zhu Z: Claudin-1 enhances tumor
proliferation and metastasis by regulating cell anoikis in gastric
cancer. Oncotarget. 6:1652–1665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS,
Hwang SG, An S, Yoon G, Gye MC, Yi JM, et al: Claudin-1 induces
epithelial-mesenchymal transition through activation of the
c-Abl-ERK signaling pathway in human liver cells. Oncogene.
32:4873–4882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kojima T, Takano K, Yamamoto T, Murata M,
Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T and Sawada
N: Transforming growth factor-beta induces epithelial to
mesenchymal transition by down-regulation of claudin-1 expression
and the fence function in adult rat hepatocytes. Liver Int.
28:534–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu QQ, Chen K, Ye Q, Jiang XH and Sun YW:
Oridonin inhibits pancreatic cancer cell migration and
epithelial-mesenchymal transition by suppressing Wnt/β-catenin
signaling pathway. Cancer Cell Int. 16:572016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY,
Xie SD and Qi ST: Akt and β-catenin contribute to TMZ resistance
and EMT of MGMT negative malignant glioma cell line. J Neurol Sci.
367:101–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Santos JC, Carrasco-Garcia E, Garcia-Puga
M, Aldaz P, Montes M, Fernandez-Reyes M, de Oliveira CC, Lawrie CH,
Araúzo-Bravo MJ, Ribeiro ML and Matheu A: SOX9 elevation acts with
canonical WNT signaling to drive gastric cancer progression. Cancer
Res. 76:6735–6746. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu T, Bao Z, Wang Y, Yang L, Lu B, Yan K,
Wang S, Wei H, Zhang Z and Cui G: Karyopherinβ1 regulates
proliferation of human glioma cells via Wnt/β-catenin pathway.
Biochem Biophys Res Commun. 478:1189–1197. 2016. View Article : Google Scholar : PubMed/NCBI
|
